Insights
![](https://bereskinparr.com/wp-content/uploads/2023/05/InsightsNews_Insights_Header_1100x515.jpg)
Updating results
Showing results 1 - 24 of 107 Results per page:
No results found.
Explore our Insights
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_417594604-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_513350803-365x487.jpg)
October 27, 2023
PMPRB Adopts Amended Interim Guidelines to Expedite New Patented Medicine Price Reviews
›![](https://bereskinparr.com/wp-content/uploads/2023/05/BP_Insights_Events_Thumb07_660x880-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_18136510-365x487.jpg)
May 5, 2023
Intellectual Property Strategy for Protecting Software: Supplementing Utility Patent Protection with Industrial Designs
›![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_191836994-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_739496338-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_62250094-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_142397470-365x487.jpg)
December 12, 2022
Getting Transparent About Transparency: Canadian Registration and Reporting of Clinical Trials
›![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_201515633-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_378224113-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_1207226602-365x487.jpg)
August 26, 2022
Is this Drug Safe and Effective Enough? Canadian Regulators Wade into Alzheimer’s Drug Controversy
›![](https://bereskinparr.com/wp-content/uploads/2023/05/BP_Insights_Events_Thumb07_660x880-365x487.jpg)
June 27, 2022
One person’s trash is another person’s treasure – Where France goes, will others follow?
›Subscribe to our newsletter
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_158577809-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_201515633-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_219242479-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_324734822-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_1676651968-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/04/BP_Insights_Events_Thumb08_660x880-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_378224113-365x487.jpg)
![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_739496338-365x487.jpg)
November 25, 2021
Licensing of COVID-19 Diagnostic IP to Facilitate Fast Access in the Third World
›![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_1572203692-365x487.jpg)
November 17, 2021
Medicines Patent Pool Gets Big Wins in Accessing Breakthrough COVID-19 Drugs for the Third World
›![](https://bereskinparr.com/wp-content/uploads/2023/09/BP_News_Events_EXTRAS_660x880_1676651968-365x487.jpg)
November 16, 2021
One Person’s Trash is Another Person’s Treasure Part IV: The Right to Repair Movement – U.K. Update
›![](https://bereskinparr.com/wp-content/uploads/2023/04/BP_Insights_Events_Thumb09_660x880-365x487.jpg)
November 9, 2021
A Healthy Dose of Skepticism From Regulators Leads to a Safe and Effective Dose of COVID-19 Drugs and Vaccines
›![](https://bereskinparr.com/wp-content/uploads/2023/04/BP_Insights_Events_Thumb06_660x880-365x487.jpg)
Loading...
Showing results 1 - 24 of 107 Results per page:
No results found.